Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

1. Serum tyrosine associates with increased CSF Aβ42, reduced Aβ deposition, and cognitive improvement in MCI: modulation by confounding factors

   Shahad Mohammed Dhiaa Younis, Abdulkareem Shareef, Ashok Kumar Bishoyi +10

   МақолаNeuroscience and Neuropharmacology ResearchInternational Journal of Neuroscience20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.007753

2. Bridging the gaps in Alzheimer's disease biomarker research: From multi-omics integration to point-of-care diagnostics, a comprehensive review

   Shakhboz Khasanov, Mansur Tolibov, Nigora Daminova

   МақолаAlzheimer's disease research and treatmentsClinica Chimica Acta20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.014009